The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 6 , Pages 1326-1330 , December 2009

Coronary artery bypass graft surgery provides better survival in patients with acute coronary syndrome or ST-segment elevation myocardial infarction experiencing cardiogenic shock after percutaneous coronary intervention: A propensity score analysis

  • Fu-Chun Chiu, MD

      Affiliations

    • National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Yun-Lin County, Taiwan
    • F.-C.C. and S.-N.C. contributed equally to this work.
    • ,
  • Sheng-Nan Chang, MS, MD

      Affiliations

    • National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Yun-Lin County, Taiwan
    • F.-C.C. and S.-N.C. contributed equally to this work.
    • ,
  • Jou-Wei Lin, MPH, MD, PhD

      Affiliations

    • National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Yun-Lin County, Taiwan
    • Corresponding Author InformationAddress for reprints: Jou-Wei Lin, MPH, MD, PhD, Cardiovascular Center, National Taiwan University Hospital Yun-Lin Branch, 579 Yun-Lin Rd, Section 2, Dou-Liou City, Yun-Lin County, Taiwan, 640, or Yih-Sharng Chen, MD, PhD, Section of Cardiovascular Surgery, Department of Surgery, National Taiwan University Hospital, 7 Chung-Shan S. Rd, Section 1, Taipei, Taiwan 100.
    • ,
  • Juey-Jen Hwang, MD, PhD

      Affiliations

    • National Taiwan University Hospital Yun-Lin Branch, Dou-Liou City, Yun-Lin County, Taiwan
    • National Taiwan University Hospital, Taipei, Taiwan
    • ,
  • Yih-Sharng Chen, MD, PhD

      Affiliations

    • National Taiwan University Hospital, Taipei, Taiwan

Received 23 October 2008 ,Revised 24 February 2009 ,Accepted 20 March 2009.

References 

  1. Califf RM, Bengtson JR. Cardiogenic shock. N Engl J Med. 1994;330:1724–1730
  2. Holmes DR, Bates ER, Kleiman NS, Sadowski Z, Horgan JH, Morris DC, et al. Contemporary reperfusion therapy for cardiogenic shock: the GUSTO-I trial experience. The GUSTO-I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. J Am Coll Cardiol. 1995;26:668–674
  3. Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, et al. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med. 1991;325:1117–1122
  4. Bengtson JR, Kaplan AJ, Pieper KS, Wildermann NM, Mark DB, Pryor DB, et al. Prognosis in cardiogenic shock after acute myocardial infarction in the interventional era. J Am Coll Cardiol. 1992;20:1482–1489
  5. Sanborn TA, Sleeper LA, Bates ER, Jacobs AK, Boland J, French JK, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol. 2000;36:1123–1129
  6. Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001;141:933–939
  7. Anderson RD, Ohman EM, Holmes DR, Col I, Stebbins AL, Bates ER, et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997;30:708–715
  8. Berger PB, Holmes DR, Stebbins AL, Bates ER, Califf RM, Topol EJ. Impact of an aggressive invasive catheterization and revascularization strategy on mortality in patients with cardiogenic shock in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries (GUSTO-I) trial. An observational study. Circulation. 1997;96:122–127
  9. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock?. N Engl J Med. 1999;341:625–634
  10. Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation. 2003;107:2998–3002
  11. White HD, Assmann SF, Sanborn TA, Jacobs AK, Webb JG, Sleeper LA, et al. Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial. Circulation. 2005;112:1992–2001
  12. Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med. 1997;127:757–763
  13. Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, et al. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J. 2007;28:1334–1343
  14. Allen BS, Rosenkranz E, Buckberg GD, Davtyan H, Laks H, Tillisch J, et al. Studies on prolonged acute regional ischemia. VI. Myocardial infarction with left ventricular power failure: a medical/surgical emergency requiring urgent revascularization with maximal protection of remote muscle. J Thorac Cardiovasc Surg. 1989;98:691–702discussion 702-3
  15. Webb JG, Sanborn TA, Sleeper LA, Carere RG, Buller CE, Slater JN, et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK Trial Registry. Am Heart J. 2001;141:964–970
  16. Zeymer U, Vogt A, Zahn R, Weber MA, Tebbe U, Gottwik M, et al. Predictors of in-hospital mortality in 1333 patients with acute myocardial infarction complicated by cardiogenic shock treated with primary percutaneous coronary intervention (PCI): results of the primary PCI registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK). Eur Heart J. 2004;25:322–328
  17. Allen BS, Buckberg GD, Fontan FM, Kirsh MM, Popoff G, Beyersdorf F, et al. Superiority of controlled surgical reperfusion versus percutaneous transluminal coronary angioplasty in acute coronary occlusion. J Thorac Cardiovasc Surg. 1993;105:864–879discussion 879-84
  18. Maxey TS, Reece TB, Ellman PI, Butler PD, Kern JA, Tribble CG, et al. Coronary artery bypass with ventricular restoration is superior to coronary artery bypass alone in patients with ischemic cardiomyopathy. J Thorac Cardiovasc Surg. 2004;127:428–434
  19. Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, et al. One-year survival following early revascularization for cardiogenic shock. JAMA. 2001;285:190–192
  20. Shawl FA, Domanski MJ, Hernandez TJ, Punja S. Emergency percutaneous cardiopulmonary bypass support in cardiogenic shock from acute myocardial infarction. Am J Cardiol. 1989;64:967–970
  21. Webb JG, Sleeper LA, Buller CE, Boland J, Palazzo A, Buller E, et al. Implications of the timing of onset of cardiogenic shock after acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol. 2000;36:1084–1090
  22. Jeger RV, Harkness SM, Ramanathan K, Buller CE, Pfisterer ME, Sleeper LA, et al. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J. 2006;27:664–670

PII: S0022-5223(09)00484-X

doi: 10.1016/j.jtcvs.2009.03.038

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 6 , Pages 1326-1330 , December 2009

Article Tools